Literature DB >> 16923159

Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells.

Hao Hong1, Ying Lu, Zhao-Ning Ji, Guo-Qing Liu.   

Abstract

Glutathione (GSH) depletion has been implicated in the pathogenesis of neurological diseases. During GSH depletion, cells of the blood-brain barrier (BBB) are subjected to chronic oxidative stress. In this study, we investigated the effect of such stress, produced with the GSH synthesis inhibitor l-buthionine-(S,R)-sulfoximine (BSO), on expression of P-glycoprotein (Pgp) in primary cultured rat brain microvessel endothelial cells that comprise the blood-brain barrier (BBB). Application of BSO to cell monolayers at concentrations up to 800 microm caused increases in expression of Pgp. Concentrations >or= 400 microm BSO decreased cell viability. Application of 200 microm BSO caused a significant increase in Pgp function activity, as assessed by rhodamine 123 (Rh123) accumulation experiments. At this concentration, BSO produced time-dependent decreases in levels of intracellular GSH and increases in levels of intracellular reactive oxygen species (iROS). The increases were also observed within 48 h following BSO treatment in mdr1a and mdr1b mRNA. Exposure of cells to BSO for 24 h produced maximal effects in the accumulation of iROS, and in expression and function of Pgp. The ROS scavenger N-acetylcysteine prevented ROS generation and attenuated the changes of both expression and activity of Pgp induced by BSO. Therefore, the transport of Pgp substrates may be affected by changing Pgp expression under conditions of chronic oxidative stress induced by GSH depletion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923159     DOI: 10.1111/j.1471-4159.2006.03993.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

Review 1.  Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.

Authors:  Loqman A Mohamed; Shashirekha Markandaiah; Silvia Bonanno; Piera Pasinelli; Davide Trotti
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

Review 2.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

3.  Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics.

Authors:  N A Seebacher; D R Richardson; P J Jansson
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

4.  Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues.

Authors:  Katarzyna Kuter; Przemysław Nowak; Krystyna Gołembiowska; Krystyna Ossowska
Journal:  Neurochem Res       Date:  2010-04-06       Impact factor: 3.996

5.  RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.

Authors:  Fang Chen; Arijit Ghosh; Mei Hu; Yan Long; Hongbin Sun; Lingyi Kong; Hao Hong; Susu Tang
Journal:  Neurotox Res       Date:  2017-09-04       Impact factor: 3.911

Review 6.  Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Brain Res       Date:  2015-03-18       Impact factor: 3.252

7.  Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells.

Authors:  Stephanie A Newman; Yijun Pan; Jennifer L Short; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2021-02-02       Impact factor: 4.200

8.  Reduction of brain infarction induced by a transient brain ischemia in mdr1a knockout mice.

Authors:  Michihiro Murozono; Shohei Matsumoto; Shinya Okada; Daisuke Nagaoka; Atsushi Isshiki; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2009-03-10       Impact factor: 3.996

9.  Harnessing drug resistance: using ABC transporter proteins to target cancer cells.

Authors:  Heather M Leitner; Remy Kachadourian; Brian J Day
Journal:  Biochem Pharmacol       Date:  2007-05-21       Impact factor: 5.858

Review 10.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.